Biohaven Pharma (BHVN) Tops Q2 EPS by 6c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq rallies as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NYSE: BHVN) | Delayed: 15.44 +0.28 (1.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.16 | 52 Week High | $ | |||
| Open | $15.46 | 52 Week Low | $ | |||
| Day High | $16.09 | P/E | N/A | |||
| Day Low | $15.25 | EPS | $ | |||
| Volume | 1,259,668 | |||||
